Preclinical Evaluation of JAB-2485, a Potent AURKA Inhibitor with High Selectivity and Favorable Pharmacokinetic Properties
Article in ACS Omega (May 2024)
The most recent citing publications are shown below. View all 32 publications that cite this research output on Dimensions.
Seize the engine: Emerging cell cycle targets in breast cancer
Article in Clinical and Translational Medicine (January 2024)
Expression Patterns and Relevance of FN3K, Nrf2, and NQO1 in Breast Cancers
Article in Eurasian Journal of Medicine and Oncology (January 2024)